• Nenhum resultado encontrado

Rev. Bras. Ginecol. Obstet. vol.39 número4

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Ginecol. Obstet. vol.39 número4"

Copied!
7
0
0

Texto

Loading

Imagem

Table 1 Markers of OVR before chemotherapy (T1), at 2 (T2) and at 6 months (T3) after completion of chemotherapy
Table 3 Comparative analysis of OVR markers in eumenorrheic patients before chemotherapy (T1) and 6 months after completion of chemotherapy (T3)

Referências

Documentos relacionados

Thus, damage in the nuclei that regulate the secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH) (serum levels: 0.1 mUI/ml and 1.9 mUI/ml,

Primary hypogonadism is characterized by low testosterone production and elevated levels of follicle-stimulating hor- mone (FSH) and luteinizing hormone (LH) (3)..

The following were measured in all patients: thyroid-stimulating hormone, free thyroxine, triiodothyronine, luteinizing hormone, follicle-stimulating hormone, total testosterone

Bone morphogenetic protein-6 stimulates gene expression of follicle- stimulating hormone receptor, inhibin/activin β subunits, and anti-Mullerian hormone in

This study aims to investigate the effects of Concanavalin A (Con A) and Follicle Stimulating Hormone (FSH) on the survival and activation of primordial follicles, and gene

Expression of follicle-stimulating hormone receptor (FSHR) in goat ovarian follicles and the impact of sequential culture medium on in vitro development of caprine

Abstract Objective The aim of the present study was to provide a better understanding of the speci fi c action of two follicle-stimulating hormone (FSH) isoforms ( β -follitropin

The serum levels of luteinizing hormone, follicle-stimulating hormone, testosterone, estradiol and prolactin in the patients treated with estrogen alone and estrogen plus